In Massachusetts, Yield10 Bioscience, Inc. named Sherri M. Brown, Ph.D. as a special commercial and technical advisor to the Company. Yield10 is a company developing new technologies to create step-change improvements in crop yield that enhance global food security. Dr. Brown is currently managing director of The Yield Lab, a global agrifood tech accelerator based […]
In Denmark, Novozymes posted first-quarter earnings slightly above forecasts but sales through its BioAg alliance with U.S. seeds company Monsanto Co were hit by Indian tariffs, according to Reuters. Novozymes posted operating profit (EBIT) of 1.016 billion Danish crowns ($166.43 million), in line with the same quarter last year, but slightly above the 990 million […]
In New Jersey, BASF agreed to buy almost all of Bayer’s seed assets including LibertyLink seeds and chemistry for $7 billion, assuming the Bayer acquisition of Monsanto goes through. If all goes as planned, BASF will gain 1,800 Bayer employees, 700 of them in North America and 81 Bayer sites. This is BASF’s first time […]
In Israel, Evogene Ltd. announced it had reached an important milestone in its crop disease collaboration with Monsanto Company with the demonstration of positive Fusarium resistance results with Evogene discovered genes. Additionally, Evogene announced the completion of the candidate gene discovery stage in the companies’ yield and abiotic stress collaboration, which mainly focuses on corn […]
In Missouri, Monsanto has reached a new global licensing agreement with the Broad Institute of MIT and Harvard for the use of the novel CRISPR-Cpf1 genome-editing technology in agriculture. The CRISPR-Cpf1 system represents an exciting advance in genome-editing technology, because it has potential to be a simpler and more precise tool for making targeted improvements […]
In political circles, the theme of “Better Together” has been under siege of late — barely winning (for now) in the Sctoland independence, debate, and losing unexpectedly in the Brexit vote — but it remains a theme for surviving and thriving in the advanced bioeconomy. We tipped it a few months ago, in “The Rise […]
Late last week, the extended courtship between Bayer and Monsanto, which saw the dowry offer raised four times by Bayer, resulted in a $127.50 all-cash offer for Monsanto, which Monsanto’s board accepted. A whopping $66 billion in all — one of the largest all-cash acquisitions, ever. Bayer and Monsanto put together this deck on the […]
Late last week, the extended courtship between Bayer and Monsanto, which saw the dowry offer raised four times by Bayer, resulted in a $127.50 per share all-cash offer for Monsanto, which Monsanto’s board accepted. A whopping $66 billion in all — one of the largest all-cash acquisitions, ever. Reactions to the deal fall into three […]
This season, we are conducting Strategic Intent, our 19 webinar series on major companies and their partnerships, progress and plans in the Advanced Bioeconomy. In this edition, we explored Bayer, Bunge and Monsanto in the interactive webinar format. Here are the slides from our Digest presentation, focusing on the innovations, M&A activity, target molecules and more for […]
In Switzerland, the Board of Syngenta confirmed that it has received an unsolicited proposal from Monsanto to acquire the company at a price of $45 billion (CHF449 per Syngenta share) with approximately 45 percent in cash. Reporting on the proposed acquisition has sugested that key Syngenta shareholders would back a deal which valued Syngenta at […]
